FASLG and cancer: As shown in Fig. 7, PLCSB demonstrated induction activity of apoptosis in HCT-116 cells, as indicated by increased mRNA and protein expression of Fas along with decreased FasL expression when compared with untreated cancer cells (P<0.05).